loading
前日終値:
$5.36
開ける:
$5.35
24時間の取引高:
326.35K
Relative Volume:
0.59
時価総額:
$295.52M
収益:
$163.78M
当期純損益:
$25.88M
株価収益率:
2.3946
EPS:
2.27
ネットキャッシュフロー:
$-28.66M
1週間 パフォーマンス:
-12.70%
1か月 パフォーマンス:
-29.11%
6か月 パフォーマンス:
-35.66%
1年 パフォーマンス:
-19.08%
1日の値動き範囲:
Value
$5.19
$5.49
1週間の範囲:
Value
$5.19
$6.1499
52週間の値動き範囲:
Value
$5.19
$11.72

Voyager Therapeutics Inc Stock (VYGR) Company Profile

Name
名前
Voyager Therapeutics Inc
Name
セクター
Healthcare (1195)
Name
電話
857-259-5340
Name
住所
75 HAYDEN AVENUE, LEXINGTON, MA
Name
職員
162
Name
Twitter
@VoyagerTx
Name
次回の収益日
2024-11-04
Name
最新のSEC提出書
Name
VYGR's Discussions on Twitter

VYGR を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
VYGR 5.425 295.52M 163.78M 25.88M -28.66M 2.27
VRTX 449.95 115.43B 10.63B -479.80M -1.35B 13.33
REGN 745.89 82.04B 13.85B 4.65B 3.32B 35.06
ARGX 591.92 35.30B 1.86B -40.29M -1.28B -4.16
ALNY 246.15 32.04B 2.09B -332.26M 16.06M -4.14
BNTX 107.33 24.89B 3.30B -501.07M 1.03B 11.54

Voyager Therapeutics Inc Stock (VYGR) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2023-05-10 開始されました Truist Buy
2023-03-10 開始されました Oppenheimer Outperform
2021-10-07 アップグレード Robert W. Baird Neutral → Outperform
2021-02-26 ダウングレード Robert W. Baird Outperform → Neutral
2021-02-03 ダウングレード BTIG Research Buy → Neutral
2021-02-03 ダウングレード Wedbush Outperform → Neutral
2020-12-24 ダウングレード Cantor Fitzgerald Overweight → Neutral
2020-12-23 ダウングレード Raymond James Outperform → Mkt Perform
2020-11-11 ダウングレード Oppenheimer Outperform → Perform
2020-11-10 ダウングレード Raymond James Strong Buy → Outperform
2020-11-10 ダウングレード Wells Fargo Overweight → Equal Weight
2020-03-19 開始されました The Benchmark Company Buy
2020-02-06 開始されました Oppenheimer Outperform
2018-11-15 アップグレード Raymond James Outperform → Strong Buy
2018-09-10 再開されました BTIG Research Buy
2018-09-10 ダウングレード Morgan Stanley Overweight → Equal-Weight
2018-06-04 開始されました H.C. Wainwright Buy
2018-03-12 ダウングレード Evercore ISI Outperform → In-line
2018-03-12 ダウングレード Wedbush Outperform → Neutral
2018-02-02 開始されました Morgan Stanley Overweight
2017-11-28 再開されました Piper Jaffray Overweight
2017-10-31 開始されました Robert W. Baird Outperform
2017-10-27 開始されました Canaccord Genuity Buy
2017-10-23 繰り返されました Stifel Buy
2017-10-12 開始されました Raymond James Outperform
2017-08-17 開始されました Evercore ISI Outperform
2017-07-28 再開されました Stifel Buy
すべてを表示

Voyager Therapeutics Inc (VYGR) 最新ニュース

pulisher
Nov 20, 2024

Voyager Selects Tau Silencing Gene Therapy Development Candidate for Alzheimer’s Disease - GlobeNewswire

Nov 20, 2024
pulisher
Nov 20, 2024

Voyager's New Alzheimer's Gene Therapy Shows 73% Tau Reduction in Key Study | VYGR Stock News - StockTitan

Nov 20, 2024
pulisher
Nov 18, 2024

Voyager Therapeutics’ TRACER Platform Targets CNS Market: Here’s Why I’m Neutral (VYGR) - Seeking Alpha

Nov 18, 2024
pulisher
Nov 18, 2024

StockNews.com Upgrades Voyager Therapeutics (NASDAQ:VYGR) to "Buy" - MarketBeat

Nov 18, 2024
pulisher
Nov 18, 2024

FY2024 Earnings Forecast for VYGR Issued By HC Wainwright - MarketBeat

Nov 18, 2024
pulisher
Nov 17, 2024

Voyager Therapeutics’ (VYGR) Buy Rating Reiterated at Canaccord Genuity Group - Defense World

Nov 17, 2024
pulisher
Nov 17, 2024

Voyager Therapeutics’ (VYGR) Buy Rating Reiterated at HC Wainwright - Defense World

Nov 17, 2024
pulisher
Nov 15, 2024

When the Price of (VYGR) Talks, People Listen - Stock Traders Daily

Nov 15, 2024
pulisher
Nov 15, 2024

Voyager Therapeutics stock hits 52-week low at $5.71 - Investing.com India

Nov 15, 2024
pulisher
Nov 15, 2024

EcoR1 Capital, LLC Increases Stake in Voyager Therapeutics Inc - GuruFocus.com

Nov 15, 2024
pulisher
Nov 15, 2024

Leerink Partnrs Has Negative Outlook of VYGR FY2024 Earnings - MarketBeat

Nov 15, 2024
pulisher
Nov 14, 2024

Voyager Therapeutics' (VYGR) Buy Rating Reiterated at Canaccord Genuity Group - MarketBeat

Nov 14, 2024
pulisher
Nov 14, 2024

Voyager Therapeutics Stock: A Deep Dive Into Analyst Perspectives (4 Ratings) - Benzinga

Nov 14, 2024
pulisher
Nov 14, 2024

Voyager Therapeutics (NASDAQ:VYGR) Earns Buy Rating from HC Wainwright - MarketBeat

Nov 14, 2024
pulisher
Nov 14, 2024

Declining Stock and Decent Financials: Is The Market Wrong About Voyager Therapeutics, Inc. (NASDAQ:VYGR)? - Yahoo Finance

Nov 14, 2024
pulisher
Nov 13, 2024

Earnings call: Voyager Therapeutics focuses on neurological therapies By Investing.com - Investing.com Canada

Nov 13, 2024
pulisher
Nov 13, 2024

Voyager Therapeutics, Inc. (NASDAQ:VYGR) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 13, 2024
pulisher
Nov 13, 2024

Voyager Therapeutics: Q3 Earnings Snapshot - Darien Times

Nov 13, 2024
pulisher
Nov 13, 2024

Voyager Therapeutics Inc earnings beat by $0.29, revenue topped estimates - Investing.com Australia

Nov 13, 2024
pulisher
Nov 13, 2024

Voyager Therapeutics Inc (VYGR) Q3 2024 Earnings Call Highlights: Strong Cash Position and ... - Yahoo Finance

Nov 13, 2024
pulisher
Nov 12, 2024

Voyager Therapeutics Reports Strong Q3 2024 Progress - TipRanks

Nov 12, 2024
pulisher
Nov 12, 2024

Voyager Therapeutics Inc (VYGR) Q3 2024 Earnings: Revenue Soars to $24.63M, EPS Loss of $0.16 Beats Estimates - GuruFocus.com

Nov 12, 2024
pulisher
Nov 12, 2024

Voyager Therapeutics (VYGR) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Finance

Nov 12, 2024
pulisher
Nov 12, 2024

Voyager Reports Third Quarter 2024 Financial and Operating Results - GlobeNewswire

Nov 12, 2024
pulisher
Nov 12, 2024

Voyager Therapeutics Revenue Soars 435% in Q3, Secures $15M Novartis Deal | VYGR Stock News - StockTitan

Nov 12, 2024
pulisher
Nov 12, 2024

Voyager Therapeutics Inc (VYGR) Q3 2024 Earnings Call Highlights: Strong Cash Position and ... By GuruFocus - Investing.com Canada

Nov 12, 2024
pulisher
Nov 10, 2024

Voyager Therapeutics (NASDAQ:VYGR) Cut to Hold at StockNews.com - MarketBeat

Nov 10, 2024
pulisher
Nov 08, 2024

Gene Therapy Market to Grow by USD 6.74 Billion from 2024-2028, as Rise in Special Drug Designations Drives Demand with AI-Powered Market EvolutionTechnavio - The Malaysian Reserve

Nov 08, 2024
pulisher
Nov 06, 2024

Voyager Therapeutics (VYGR) to Release Quarterly Earnings on Tuesday - MarketBeat

Nov 06, 2024
pulisher
Nov 06, 2024

Voyager Therapeutics to Present at Multiple Upcoming Investor Conferences - The Manila Times

Nov 06, 2024
pulisher
Nov 06, 2024

Voyager Therapeutics to Present at 4 Major Healthcare Investor Conferences in November | VYGR Stock News - StockTitan

Nov 06, 2024
pulisher
Nov 05, 2024

Voyager Therapeutics Announces Third Quarter 2024 Conference Call and Webcast - GlobeNewswire

Nov 05, 2024
pulisher
Nov 05, 2024

VYGRVoyager Therapeutics, Inc. Latest Stock News & Market Updates - StockTitan

Nov 05, 2024
pulisher
Nov 05, 2024

Voyager Therapeutics (VYGR) to Report Q3 2024 Earnings on November 12 | VYGR Stock News - StockTitan

Nov 05, 2024
pulisher
Nov 05, 2024

Learn to Evaluate (VYGR) using the Charts - Stock Traders Daily

Nov 05, 2024
pulisher
Nov 04, 2024

Strength Seen in Voyager Therapeutics (VYGR): Can Its 17.5% Jump Turn into More Strength? - MSN

Nov 04, 2024
pulisher
Nov 02, 2024

Voyager Therapeutics (NASDAQ:VYGR) Rating Increased to Buy at StockNews.com - MarketBeat

Nov 02, 2024
pulisher
Oct 28, 2024

Voyager Therapeutics (VYGR) Expected to Beat Earnings Estimates: Can the Stock Move Higher? - Yahoo Canada Finance

Oct 28, 2024
pulisher
Oct 28, 2024

Brokerages Set Voyager Therapeutics, Inc. (NASDAQ:VYGR) PT at $17.43 - MarketBeat

Oct 28, 2024
pulisher
Oct 28, 2024

Voyager Therapeutics, Inc. (NASDAQ:VYGR) Receives Average Rating of “Buy” from Analysts - Defense World

Oct 28, 2024
pulisher
Oct 27, 2024

Voyager Therapeutics (NASDAQ:VYGR) Stock Rating Lowered by StockNews.com - Defense World

Oct 27, 2024
pulisher
Oct 26, 2024

StockNews.com Lowers Voyager Therapeutics (NASDAQ:VYGR) to Hold - MarketBeat

Oct 26, 2024
pulisher
Oct 25, 2024

How to Take Advantage of moves in (VYGR) - Stock Traders Daily

Oct 25, 2024
pulisher
Oct 24, 2024

HC Wainwright Reaffirms Buy Rating for Voyager Therapeutics (NASDAQ:VYGR) - MarketBeat

Oct 24, 2024
pulisher
Oct 22, 2024

Viral Vectors-Based Gene Therapy for Non-Human Primates Market - openPR

Oct 22, 2024
pulisher
Oct 22, 2024

Neurologic Disorders Therapeutics Strategic Business Report - GlobeNewswire

Oct 22, 2024
pulisher
Oct 18, 2024

Equities Analysts Offer Predictions for VYGR Q3 Earnings - MarketBeat

Oct 18, 2024
pulisher
Oct 18, 2024

Voyager Therapeutics (NASDAQ:VYGR) Rating Increased to Strong-Buy at Leerink Partnrs - Defense World

Oct 18, 2024
pulisher
Oct 17, 2024

Voyager Therapeutics (NASDAQ:VYGR) Upgraded to "Strong-Buy" by Leerink Partnrs - MarketBeat

Oct 17, 2024

Voyager Therapeutics Inc (VYGR) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$18.98
price up icon 1.80%
$70.68
price down icon 0.42%
$38.38
price up icon 3.49%
$369.83
price up icon 1.48%
$196.58
price up icon 0.88%
$102.64
price up icon 0.27%
大文字化:     |  ボリューム (24 時間):